A new cytotoxic xanthone from Garcinia rigida

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Medicinal Chemistry

Background:

• Garcinia species are a rich source of bioactive compounds, including xanthones.
• Xanthones exhibit a wide range of pharmacological activities, such as anticancer and anti-inflammatory properties.
• Garcinia rigida is traditionally used in some regions, but its chemical constituents and bioactivity require further investigation.

Purpose of the Study:

• To isolate and characterize new chemical entities from Garcinia rigida leaves.
• To evaluate the cytotoxic potential of isolated compounds against cancer cell lines.
• To identify novel anticancer leads from natural sources.

Main Methods:

• Phytochemical investigation of Garcinia rigida leaf extract using chromatographic techniques.
• Structure elucidation of the isolated compound using spectroscopic methods (e.g., NMR, MS).
• In vitro cytotoxicity assay using L1210 leukemia cell line to determine the IC50 value.

Main Results:

• A new xanthone, designated yahyaxanthone (1), was successfully isolated and identified.
• Yahyaxanthone (1) exhibited notable cytotoxicity against L1210 leukemia cells.
• The half-maximal inhibitory concentration (IC50) of yahyaxanthone (1) was determined to be 4.08 microg/ml.

Conclusions:

• Yahyaxanthone (1) represents a novel xanthone derivative with promising cytotoxic activity.
• The findings suggest that Garcinia rigida is a valuable source for discovering new anticancer agents.
• Further studies are warranted to explore the mechanism of action and therapeutic potential of yahyaxanthone (1).